Estrogen receptor (ER) mediates 17-estradiol (E2)-activated expression of HBO1

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Wang, Wen Zhong ^a   Liu, Hai Ou ^a,b   Wu, Yi Hong ^a   Hong, Yi ^a   Yang, Jun Wu ^a   Liu, Ye Heng ^a   Wu, Wei Bin ^a   Zhou, Lei ^a   Sun, Lin Lin ^a,b   Xu, Jie Jie ^a   Yun, Xiao Jing ^a   Gu, Jian Xin ^a  

^a FUDAN UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE BINDING TO ORC1; MESSENGER RNA; PROGESTERONE; UNCLASSIFIED DRUG; MAPK1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYST2 PROTEIN, HUMAN; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOSYNTHESIS; BREAST TUMOR; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE ACETYLTRANSFERASES; HUMANS; IMMUNOHISTOCHEMISTRY; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 77958616319     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-140     Document Type: Article

References (29)

1. Global cancer statistics, 2002. DM Parkin F Bray J Ferlay P Pisani, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078
2. Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male Noble rat: probable mediation by steroid receptors. DZ Liao CG Pantazis X Hou SA Li, Carcinogenesis 1998 19 2173 80 10.1093/carcin/19.12.2173 9886575
3. Role of estrogen receptor beta in estrogen action. K Pettersson JA Gustafsson, Annu Rev Physiol 2001 63 165 92 10.1146/annurev.physiol.63.1.165 11181953
4. Dietary modulation of pregnancy estrogen levels and breast cancer risk among female rat offspring. L Hilakivi-Clarke E Cho A Cabanes,, et al. Clin Cancer Res 2002 8 3601 10 12429652
5. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. R Clarke MC Liu KB Bouker,, et al. Oncogene 2003 22 7316 39 10.1038/sj.onc.1206937 14576841
6. Genomic targets of nuclear estrogen receptors. R O'Lone MC Frith EK Karlsson U Hansen, Mol Endocrinol 2004 18 1859 75 10.1210/me.2003-0044 15031323
7. Histone acetyltransferase Hbo1: catalytic activity, cellular abundance, and links to primary cancers. M Iizuka Y Takahashi CA Mizzen,, et al. Gene 2009 436 108 14 10.1016/j.gene.2009.01.020 19393168
8. Genetic alterations and oncogenic pathways associated with breast cancer subtypes. X Hu HM Stern L Ge,, et al. Mol Cancer Res 2009 7 511 22 10.1158/1541-7786.MCR-08-0107 19372580
9. Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription. M Georgiakaki N Chabbert-Buffet B Dasen,, et al. Mol Endocrinol 2006 20 2122 40 10.1210/me.2005-0149 16645042
10. Repression of estrogen receptor alpha by CDK11p58 through promoting its ubiquitin-proteasome degradation. Y Wang H Zong Y Chi,, et al. J Biochem 2009 145 331 43 10.1093/jb/mvn177 19122208
11. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. W Remmele HE Stegner, Pathologe 1987 8 138 40 3303008
12. Basic guide to the mechanisms of antiestrogen action. JI MacGregor VC Jordan, Pharmacol Rev 1998 50 151 96 9647865
13. Similarities and distinctions in the mode of action of different classes of antioestrogens. AE Wakeling, Endocr Relat Cancer 2000 7 17 28 10.1677/erc.0.0070017 10808193
14. Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones. J Clark S Edwards M John,, et al. Genes Chromosomes Cancer 2002 34 104 14 10.1002/gcc.10039 11921288
15. Impact of DNA amplification on gene expression patterns in breast cancer. E Hyman P Kauraniemi S Hautaniemi,, et al. Cancer Res 2002 62 6240 5 12414653
16. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. JR Pollack T Sorlie CM Perou,, et al. Proc Natl Acad Sci USA 2002 99 12963 8 10.1073/pnas.162471999 12297621
17. HBO1 histone acetylase is a coactivator of the replication licensing factor Cdt1. B Miotto K Struhl, Genes Dev 2008 22 2633 8 10.1101/gad.1674108 18832067
18. Estrogen carcinogenesis in breast cancer. JD Yager NE Davidson, N Engl J Med 2006 354 270 82 10.1056/NEJMra050776 16421368
19. Estrogen receptor pathways in lung cancer. LP Stabile JM Siegfried, Curr Oncol Rep 2004 6 259 67 10.1007/s11912-004-0033-2 15161576
20. Estrogen receptor signaling pathways in human non-small cell lung cancer. DC Marquez-Garban HW Chen MC Fishbein L Goodglick RJ Pietras, Steroids 2007 72 135 43 10.1016/j.steroids.2006.11.019 17276470
21. Nuclear receptor signaling and cardiac energetics. JM Huss DP Kelly, Circ Res 2004 95 568 78 10.1161/01.RES.0000141774.29937.e3 15375023
22. Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. MR Meyer E Haas M Barton, Hypertension 2006 47 1019 26 10.1161/01.HYP.0000223064.62762.0b 16651458
23. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance. N Atanaskova VG Keshamouni JS Krueger JA Schwartz F Miller KB Reddy, Oncogene 2002 21 4000 8 10.1038/sj.onc.1205506 12037682
24. Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation. LA Martin I Farmer SR Johnston S Ali M Dowsett, Endocr Relat Cancer 2005 12 Suppl 1 75 84 10.1677/erc.1.01023 16113101
25. The role of mitogen-activated protein (MAP) kinase in breast cancer. RJ Santen RX Song R McPherson,, et al. J Steroid Biochem Mol Biol 2002 80 239 56 10.1016/S0960-0760(01)00189-3 11897507
26. Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. A Migliaccio M Pagano F Auricchio, Oncogene 1993 8 2183 91 7687761
27. Epidermal growth factor induces protein tyrosine phosphorylation and association of p190 with ras-GTP-ase activating protein in Caco-2 cells. A Auricchio M di Domenico G Castoria A Bilancio A Migliaccio, FEBS Lett 1994 353 16 20 10.1016/0014-5793(94)00987-2 7926013
28. Protein tyrosine phosphorylation and estradiol action. F Auricchio A Migliaccio G Castoria M Di Domenico A Bilancio A Rotondi, Ann N Y Acad Sci 1996 784 149 72 10.1111/j.1749-6632.1996.tb16234.x 8651566
29. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. A Migliaccio D Piccolo G Castoria,, et al. EMBO J 1998 17 2008 18 10.1093/emboj/17.7.2008 9524123